Analgesics in Uruguay -
Consumers’ preference for non-steroidal anti-inflammatory drugs (NSAIDs) for fast relief of pain of different aetiology, with little or no unwanted side effects has been addressed by companies for many years with small price increases in current terms, thus favouring volume growth in most NSAIDs categories and combination analgesics. This trend ended in 2012 as prices of NSAIDs increase well above the annual variation of the general inflation, with the sole exception of diclofenac. Consumers...
Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.